Bicocca Open Archive

Logo unimib boa

Meroni, M., Mirimao, F., Craparotta, I., Panini, N., Ubezio, P., Bello, E., et al. (2023). The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma. In EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy Abstracts (pp.367-367) [10.1002/1878-0261.13471].

The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma

Meroni, M;
2023
abstract + poster
adipocytic differentiation, myxoid liposarcoma
English
EACR 2023 Congress
2023
EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy Abstracts
2023
17
S1
367
367
EACR23-0945
https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.13471
none
Meroni, M., Mirimao, F., Craparotta, I., Panini, N., Ubezio, P., Bello, E., et al. (2023). The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma. In EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy Abstracts (pp.367-367) [10.1002/1878-0261.13471].
02 - Intervento a convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/483342
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact